Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities-Reference-Cited by-同舟云学术

Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities

Published:2019-08-21 Issue:10 Volume:13 Page:2259-2277
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Di Jieyi¹,Zheng Baotong¹,Kong Qingfei²,Jiang Ying³,Liu Siyao¹,Yang Yang¹,Han Xudong¹,Sheng Yuqi¹,Zhang Yunpeng¹,Cheng Liang¹,Han Junwei¹^ORCID

Affiliation:

1. College of Bioinformatics Science and Technology Harbin Medical University China

2. Department of Neurobiology Harbin Medical University China

3. College of Basic Medical Science Heilongjiang University of Chinese Medicine Harbin China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Heilongjiang Province

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12564

Reference57 articles.

1. Drug repositioning: identifying and developing new uses for existing drugs

2. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

3. Preclinical antitumor activity of CT‐2106 (polyglutamate camptothecin) in human ovarian carcinoma xenograft;Beggiolin G;Can Res,2005

4. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

5. MicroRNA expression profiles for the NCI-60 cancer cell panel

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated edge information and pathway topology for drug-disease associations;iScience;2024-07

2. DrugRepoBank: a comprehensive database and discovery platform for accelerating drug repositioning;Database;2024

3. PathwayTMB: A pathway-based tumor mutational burden analysis method for predicting the clinical outcome of cancer immunotherapy;Molecular Therapy - Nucleic Acids;2023-12

4. Pathway2Targets: an open-source pathway-based approach to repurpose therapeutic drugs and prioritize human targets;PeerJ;2023-09-29

5. Informatics on Drug Repurposing for Breast Cancer;Drug Design, Development and Therapy;2023-06